2,282 results on '"Yeo, Charles J."'
Search Results
2. Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma
3. Major Pancreatic Resection Increases Bone Mineral Density Loss, Osteoporosis, and Fractures
4. Peripancreatic fluid collections following distal pancreatectomy and splenectomy—when is intervention warranted?
5. Early Postoperative Vital Signs Predict Subsequent 90-Day Mortality After Pancreaticoduodenectomy
6. Impact of antecolic vs transmesocolic reconstruction on delayed gastric emptying following pancreaticoduodenectomy
7. Salvage endoscopic ultrasound-guided gastrojejunostomy as a bridge to definitive surgical therapy for duodenal adenocarcinoma presenting with duodenal stent obstruction
8. Incisional hernia after major pancreatic resection: long term risk assessment from two distinct sources – A large multi-institutional network and a single high-volume center
9. The Financial Implications of Pancreatic Surgery: The Hospital Is the Big Winner, Not the Surgeon!
10. Implementation of an opioid reduction toolkit in pancreatectomy patients significantly increases patient awareness of safe practice and decreases amount prescribed and consumed
11. Sphincteroplasty
12. Preoperative sarcopenia is a negative predictor for enhanced postoperative recovery after pancreaticoduodenectomy
13. Hemorrhage Sites and Mitigation Strategies After Pancreaticoduodenectomy
14. Pharmacokinetics of apixaban in patients undergoing pancreaticoduodenectomy (PAP-UP)
15. Cyst Fluid Biosignature to Predict Intraductal Papillary Mucinous Neoplasms of the Pancreas with High Malignant Potential
16. Beauty Borne out of Chaos: Molding a Surgical Subspecialty Through the World Wars
17. A dynamic risk factor assessment for myocardial infarction and cardiac arrest in patients undergoing pancreatectomy
18. The Imperative of Assessing Quality of Life in Patients Presenting to a Pancreaticobiliary Surgery Clinic
19. A brief history of the office of the Surgeon General and the 2 surgeons who have held the position
20. Association of Mutant KRAS Alleles With Morphology and Clinical Outcomes in Pancreatic Ductal Adenocarcinoma
21. Contemporary report of surgical outcomes after single‐stage total pancreatectomy: A 10‐year experience
22. Association between TP53 gain of function and loss of function mutational subgroups and survival in pancreatic adenocarcinoma.
23. Abstract B006: Targeting BARD1 in human pancreatic ductal adenocarcinoma: How to expand the target population of vulnerable tumors?
24. Warren B. Davis and the Birth of Plastic Surgery in Philadelphia: A Historical Vignette
25. Response to Comment on Paper Titled “Is It Safe to Manage Acute Cholecystitis Nonoperatively During Pregnancy?: A Nationwide Analysis of Morbidity According to Management Strategy”
26. Pancreatic Cancer
27. Is the Use of Intraoperative Frozen Section During Pancreaticoduodenectomy Justified?
28. Racial Disparities in Rates of Surgery for Esophageal Cancer: a Study from the National Cancer Database
29. Margin-Positive Pancreatic Ductal Adenocarcinoma during Pancreaticoduodenectomy: Additional Resection Does Not Improve Survival
30. Caregiver‐reported quality of communication in pancreatic and periampullary cancer.
31. The Clinical Implications of KRAS Mutations and Variant Allele Frequencies in Pancreatic Ductal Adenocarcinoma.
32. International Expert Consensus on Defining Textbook Oncologic Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastasis.
33. Management of the pancreatic transection plane after left (distal) pancreatectomy: Expert consensus guidelines by the International Study Group of Pancreatic Surgery (ISGPS)
34. A step towards personalizing next line therapy for resected pancreatic and related cancer patients: A single institution's experience
35. Effect of Hypercapnia, an Element of Obstructive Respiratory Disorder, on Pancreatic Cancer Chemoresistance and Progression
36. Response to Comment on Paper Titled ‘Is It Safe to Manage Acute Cholecystitis Nonoperatively During Pregnancy?: A Nationwide Analysis of Morbidity According to Management Strategy’
37. Caregiver‐reported quality of communication in pancreatic and periampullary cancer
38. The Financial Implications of Pancreatic Surgery: The Hospital Is the Big Winner, Not the Surgeon!
39. A Resident-Driven Quality Initiative for Reducing Opioid Prescribing in Patients Undergoing Elective General Surgery Procedures, With Long-Term Follow-Up
40. Early Outcomes of MR-guided SBRT for Patients with Recurrent Pancreatic Adenocarcinoma
41. Postpancreatectomy Acute Pancreatitis (PPAP): Definition and Grading from the International Study Group for Pancreatic Surgery (ISGPS)
42. A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
43. Optimizing cancer cure dialog: an analysis of pancreatic cancer patients’ views regarding survival and cure
44. Surgical Outcomes After Pancreatic Resection of Screening-Detected Lesions in Individuals at High Risk for Developing Pancreatic Cancer
45. Precision Medicine Based on Next-Generation Sequencing and Master Controllers
46. Invaginating Pancreaticojejunostomy: How I Do It
47. Fundamentals of the Daily Routine as a Surgeon: Philosophy, Mentors, Coaches, and Success
48. Enhancing Patient Outcomes while Containing Costs after Complex Abdominal Operation: A Randomized Controlled Trial of the Whipple Accelerated Recovery Pathway
49. Survival and Late Morbidity after Resection of Pancreatic Cancer
50. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.